“We have to learn to live with COVID-19” is a phrase we’ve been hearing all too often these days. Health Minister Khairy Jamaluddin has reiterated that we need to reopen safely and to start treating COVID-19 as endemic. Our neighbour down south, Singapore, has stayed the course of reopening the economy, despite rising COVID-19 cases. Over in New Zealand, Prime Minister Jacinda Ardern has finally dropped their zero-COVID strategy as the Delta variant persists. But are we truly ready to treat COVID-19 as endemic? Well, ready or not, the virus is likely here to stay. Prof Dr Ooi Eng Eong from the Emerging Infectious Diseases Programme at the Duke-NUS Medical School joins consultant urologist Dr George Lee to discuss how we can prepare ourselves for this new reality.

Editor's note - Prof Ooi has further clarified on the antibody & T-cell response generated by vaccines, in particular the lack of T-cell response after receiving an inactivated virus vaccine: The lack of killer T-cells may not necessarily affect the durability of immunity. Instead, without such T-cells, immunity would be reliant only on the antibodies produced from vaccination. If these are not at levels needed to protect against infection, there is no killer T-cell response to quickly remove the infected cells. In other words, there is no backup protection. 

For more on the role of boosters/third doses of the COVID-19 vaccine, listen to this podcast with infectious disease physician Dr Yasmin Gani from Hospital Sungai Buloh.

Image credit: Pexels

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  the bigger picture,  health & living,  covid-19,  sars-cov-2,  delta,  vaccines,  boosters,  endemic,  pandemic,  outbreaks,  containment,  mu,  living with covid-19,  fttis,  elimination,  mitigation

Tags: